<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04156360</url>
  </required_header>
  <id_info>
    <org_study_id>YT2019-001</org_study_id>
    <nct_id>NCT04156360</nct_id>
  </id_info>
  <brief_title>Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer</brief_title>
  <official_title>Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Pulmonary Hospital, Shanghai, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Pulmonary Hospital, Shanghai, China</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to detetct Circulating tumor cells(CTCs) and Cancer Associated&#xD;
      Macrophage-Like cells (CAMLs) in patients with pulmonary nodules using a novel microfluidic&#xD;
      CTC-detection system. Then construct an early diagnostic model for lung cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients found pulmonary nodules by CT screening will be enrolled in this study&#xD;
      prospectively. CTCs and CAMLs both are cancer specific biomarkers found in the peripheral&#xD;
      blood of patients with solid tumors including lung cancer. Through detecting CTCs and CAMLs&#xD;
      in healthy volunteers and patients with pulmonary nodules who undergo biopsy, determine the&#xD;
      cut-off value of the test. Further analysis of the test specificity and sensitivity, and on&#xD;
      this basis construct an early diagnostic model for lung cancer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">November 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of prevalence of CTCs and CAMLs in patients with pulmonary nodules</measure>
    <time_frame>12 months</time_frame>
    <description>The number of CTCs and CAMLs will be detected in the peripheral blood of patients with pulmonary nodules using a novel microfluidic CTC-detection system.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of optimal cut-off values for screening Lung Cancer paitents</measure>
    <time_frame>6 months</time_frame>
    <description>The optimal cut-off values will be determined by the ROC analyses.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Healthy</condition>
  <condition>Pulmonary Nodule</condition>
  <arm_group>
    <arm_group_label>Healthy Volunteers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients With Pulmonary Nodule</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with pulmonary nodules diagnosed by chest CT or low-dose computed tomography&#xD;
        (LDCT) scans&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female or male, 18 years of age or older&#xD;
&#xD;
          -  Pulmonary nodules diagnosed by chest CT or low-dose computed tomography (LDCT) scans&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior diagnosis of lung cancer or other invasive malignancy within the past 5 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yayi He, MD, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Pulmonary Hospital, Tongji University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yayi He, MD, PHD</last_name>
    <phone>+862165115006</phone>
    <email>2250601@qq.com</email>
  </overall_contact>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 28, 2019</study_first_submitted>
  <study_first_submitted_qc>November 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2019</study_first_posted>
  <last_update_submitted>November 5, 2019</last_update_submitted>
  <last_update_submitted_qc>November 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Pulmonary Hospital, Shanghai, China</investigator_affiliation>
    <investigator_full_name>Caicun Zhou</investigator_full_name>
    <investigator_title>Director Head of Medical Oncology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

